Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sirona Biochem's share price for the quarter that ended in Jul. 2024 was $0.0378. Sirona Biochem's Shares Outstanding (EOP) for the quarter that ended in Jul. 2024 was 258.84 Mil. Therefore, Sirona Biochem's market cap for the quarter that ended in Jul. 2024 was $9.78 Mil.
Sirona Biochem's quarterly market cap
declined
from Jan. 2024 ($16.48 Mil) to Apr. 2024 ($13.34 Mil) and
declined
from Apr. 2024 ($13.34 Mil) to Jul. 2024 ($9.78 Mil).
Sirona Biochem's annual market cap
declined
from Oct. 2021 ($35.20 Mil) to Oct. 2022 ($22.66 Mil) and
declined
from Oct. 2022 ($22.66 Mil) to Oct. 2023 ($13.57 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sirona Biochem's Enterprise Value for Today is $3.67 Mil.
Sirona Biochem (OTCPK:SRBCF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sirona Biochem Market Cap Related Terms
Sirona Biochem Market Cap Historical Data
* Premium members only.
The historical data trend for Sirona Biochem's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Sirona Biochem's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sirona Biochem Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sirona Biochem's Market Cap distribution charts can be found below:
* The bar in red indicates where Sirona Biochem's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sirona Biochem's Market Cap for the fiscal year that ended in Oct. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sirona Biochem (SRBCF) has a Market Cap of $1.32 Mil as of Aug. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sirona Biochem and its competitors.
Is Sirona Biochem's Market Cap too high?
Sirona Biochem's current Market Cap is $1.32 Mil. The Biotechnology industry median Market Cap is 117.58. Sirona Biochem's value of $1.32 Mil is 98.9% below this industry median.
How does Sirona Biochem's Market Cap compare to MTNB and TCRT?
Sirona Biochem's Market Cap of $1.32 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 117.58. Sirona Biochem's value of $1.32 Mil is 98.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.58, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sirona Biochem's current Market Cap of $1.32 Mil is 98.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sirona Biochem and its competitors. For the Biotechnology industry, the median Market Cap is 117.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sirona Biochem's current Market Cap is $1.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sirona Biochem stock overvalued right now?
Sirona Biochem (SRBCF) has a current Market Cap of $1.32 Mil. The current Market Cap is $1.32 Mil and 98.9% below the Biotechnology industry median of 117.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sirona Biochem (SRBCF), the current Market Cap is $1.32 Mil as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRBCF has been successfully added to your 
